News & Press
Women's Health Innovator Granata Bio Raises $15M Series A+ to Further Develop and Expand Reproductive Health Pipeline
Granata Bio Corporation announced a $15M Series A+ funding round. The round was exclusively supported by existing investors, including Gedeon Richter, CooperSurgical, Amboy Street Ventures, and other strategic investors. Granata has raised over $30 million to date.
IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA
IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA
Granata Bio is Partnering with RESOLVE: The National Infertility Association
Granata Bio is partnering with RESOLVE: The National Infertility Association, to better understand clinical trials from the patients’ perspective
Granata Bio CEO, Evan Sussman to Moderate Panel on Innovation in Reproductive Health
Granata Bio is excited to have Dr. Denny Sakkas from Boston IVF, Dr. Lynn Westphal from Kindbody and Dr. Ken Carson from Tempus Labs, Inc. participate in a panel discussion on Innovation in Drug Discovery, R&D & Reproductive Health, moderated by our CEO, Evan Sussman. At this year’s Reproductive Health Innovative Summit on February 15-16 in Boston, MA.